After being diagnosed with MS in 2018 and going into remission in 2021, the actress takes to Instagram on January 29th to share how she’s doing with her fans.
Multiple Sclerosis
Dr John Campbell’s ridiculous WHO vaccine/multiple sclerosis claims
Christina Applegate Reveals She Had Multiple Sclerosis for 7 Years Before Diagnosis
In a sit-down with ‘Good Morning America’ alongside friend Jamie-Lynn Sigler, the ‘Dead to Me’ star opens up about her battle with Multiple Sclerosis.
Thriving with Multiple Sclerosis
Making small changes in your life can and will lead to positive outcomes in the future. Becoming more engaged in life and not sweating the small stuff. To have the courage to step through the doors life presents and then maybe to go on a journey you never imagined. Diagnosed with Multiple Sclerosis in 1995, Rob has taken on the challenge of a TEDx talk the way he deals with pretty much everything.
Researchers discover first genetic marker for severity of Multiple Sclerosis
A study of more than 22,000 people with multiple sclerosis (MS) has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time. The work resulted from a large international collaboration of more than 70 institutions worldwide, led by researchers from UCSF (USA) and the University of Cambridge (UK). About 3 million people live with multiple sclerosis or MS, but the real number may be higher. Women are more likely to develop MS than men. When diagnosed, the immune system attacks the central nervous system, causing symptoms that range from numbness to disability. Although scientists know MS is associated with genetic risks, MS is not an inherited disease, and doctors have struggled to understand why some cases progress faster than others. This latest study combed through 13,000 patients’ DNA and found a gene that is linked to the onset of severe disability. Sergio Baranzini is a Neurology Professor at the University of California San Francisco. He is the study’s lead author, and he joins us live from San Francisco to discuss the latest updates.